G
Genelux Corporation (GNLX)
NCM – Real vaqt narxi. Valyuta: USD
2.97
+0.07 (2.41%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.97
+0.07 (2.41%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Genelux Corporation, klinik bosqichdagi biofarmatsevtika kompaniyasi, agressiv va/yoki davolash qiyin bo'lgan qattiq o'smalardan aziyat chekayotgan bemorlar uchun onkolitik virusli immunoterapiyalarni ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodi Olvi-Vec (olvimulogene nanivacirepvec) bo'lib, bu tuxumdon saratonini davolash uchun ko'rsatilgan propriyetar modifikatsiyalangan poksvirus shtammi. U, shuningdek, texnologiya va kashfiyot hamda ishlab chiqish platformasi bo'lgan CHOICEni taklif etadi; va izolyatsiya qilingan va muhandislik qilingan onkolitik poksvirusli immunoterapiya mahsulot nomzodlarining keng qamrovli kutubxonasini ishlab chiqdi. Kompaniya Xitoyda, jumladan, Xitoy materigi, Tayvan, Gonkong va Makao hududlarida Olvi-Vecni inson diagnostikasi, profilaktikasi va terapevtik maqsadlarda tadqiq qilish, ishlab chiqish, tijoratlashtirish yoki undan foydalanish bo'yicha Newsoara BioPharma Co. Ltd. bilan litsenziyalash shartnomasiga ega. Genelux Corporation 2001-yilda tashkil etilgan va Kaliforniyaning Vestleyk Villag shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jason B. Litten M.D. | Chief Medical Officer |
| Dr. Joseph Cappello Ph.D. | Chief Technical Officer |
| Dr. Yong Yu Ph.D. | Senior Vice President of Clinical Development |
| Mr. Eric Groen J.D. | General Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business Development |
| Mr. Matthew Pulisic M.B.A. | CFO and Principal Financial & Accounting Officer |
| Mr. Ralph Smalling B.Sc. | VP & Head of Regulatory Affairs |
| Mr. Thomas D. Zindrick J.D. | Chairman, CEO & President |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | form10-q.htm |
| 2026-04-29 | DEFA14A | formdefa14a.htm |
| 2026-04-29 | DEF 14A | formdef14a.htm |
| 2026-03-19 | S-8 | forms-8.htm |
| 2026-02-02 | 8-K | form8-k.htm |
| 2026-01-08 | 8-K | form8-k.htm |
| 2026-01-05 | 8-K | form8-k.htm |
| 2026-01-02 | 8-K | form8-k.htm |
| 2025-11-05 | 10-Q | form10-q.htm |
| 2025-09-03 | 8-K | form8-k.htm |